ArticleResearch square2025

ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis.

Linda Harrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.